AMBA vs MRK · rev $284.9M vs P/E 33, rev $65.01B
Ambarella Inc (AMBA) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Ambarella Inc (AMBA) is a semiconductor equipment & materials company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported AMBA revenue for 2025-01-31 was $284.9M. Net income was -$117.1M. Revenue was up 25.8% from 2024-01-31 to 2025-01-31. AMBA currently screens at market cap $2.86B.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
AMBA currently screens at market cap $2.86B. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the AMBA and MRK stock pages for the full models.
Not investment advice.